Literature DB >> 18753360

Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.

Ahmet Alacacioglu1, Isil Somali, Ilkay Simsek, Ibrahim Astarcioglu, Metin Ozkan, Cemalettin Camci, Necati Alkis, Aziz Karaoglu, Oktay Tarhan, Tugba Unek, Ugur Yilmaz.   

Abstract

OBJECTIVE: Hepatocellular cancer (HCC) is one of the important health problems in Turkey. We aimed to determine the clinical and demographic features of HCC in the Turkish population and to evaluate the prognostic and survival features.
METHOD: Two hundred and twenty-one patients with HCC from five hospitals in Turkey are included in this study.
RESULTS: In 44.4% of the 221 patients with hepatitis B virus and in 21.3% of the 221 patients with hepatitis C virus were found to be responsible for HCC etiology. It has been shown that HCC developed on cirrhosis basis in 74.2% of the patients. HCC was presented with single solitary nodule in 69.2% of the patients. Non-liver metastasis was present in 12.5% of the patients. In 21.7% of the patients, alpha-fetoprotein (AFP) levels were above the diagnostics level of 400 ng/ml. The median overall survival (OS) of 221 patients was 14 months. The median OS of the patients with Child-Pugh A class was significantly longer than that with Child-Pugh B and C classes. The OS of the individuals with normal AFP levels was also longer than that with high AFP levels. The OS of the patients with Stage I HCC according to tumor node metastasis (TNM) classification, the female patients and the treated patients group was found to be significantly good.
CONCLUSIONS: In conclusion, the viral etiology (hepatitis B and C infections) in Turkish population is found to be an important factor in HCC development. The Child-Pugh classification, AFP levels, TNM classification, being female and treatment were determined to be important prognostic factors in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753360     DOI: 10.1093/jjco/hyn082

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  20 in total

1.  Wide Sexual Dimorphism of Hepatocellular Carcinoma Presentation in Algeria.

Authors:  Yazid Chikhi; Salima Cheraitia; Rachid Ould Gougam; Fadila Lounes; Chahrazed Zemmouchi; Nassila Belal; Maroua Bendaoud; Sonia Ait Younes; Aicha Bensalem; Saadi Berkane; Hocine Asselah; Pascal Pineau; Mustapha Lahcene
Journal:  Gastrointest Tumors       Date:  2019-08-30

2.  CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.

Authors:  Ji-Bin Liu; Yi-Xin Zhang; Shu-Hui Zhou; Min-Xin Shi; Jin Cai; Yan Liu; Ke-Ping Chen; Fu-Lin Qiang
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

3.  Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study.

Authors:  Yunus Gürbüz; Necla Eren Tülek; Emin Ediz Tütüncü; Süda Tekin Koruk; Bilgehan Aygen; Neşe Demirtürk; Sami Kınıklı; Ali Kaya; Taner Yıldırmak; Kaya Süer; Fatime Korkmaz; Onur Ural; Sıla Akhan; Özgür Günal; Nazan Tuna; Şükran Köse; İbak Gönen; Bahar Örmen; Nesrin Türker; Neşe Saltoğlu; Ayşe Batırel; Günay Tuncer; Cemal Bulut; Fatma Sırmatel; Asım Ulçay; Ergenekon Karagöz; Derviş Tosun; Alper Şener; Aynur Aynıoğlu; Elif Sargın Altunok
Journal:  Balkan Med J       Date:  2016-01-01       Impact factor: 2.021

4.  Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections.

Authors:  Saba Khan; Arpit Bhargava; Neelam Pathak; Kewal K Maudar; Subodh Varshney; Pradyumna K Mishra
Journal:  Indian J Clin Biochem       Date:  2011-01-05

5.  Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Authors:  Gabriele Kirchner; Georgi Kirovski; Alexandra Hebestreit; Jürgen Schölmerich; Hans Jürgen Schlitt; Oliver Stoeltzing; Claus Hellerbrand
Journal:  Int J Clin Exp Med       Date:  2010-06-10

6.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

7.  Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients.

Authors:  Priyanka Iyer; Abdel-Rahman Zekri; Chu-Wei Hung; Emily Schiefelbein; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Amr S Soliman
Journal:  Exp Mol Pathol       Date:  2009-10-07       Impact factor: 3.362

8.  Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study.

Authors:  Nazim Serdar Turhal; Berna Savaş; Öznur Çoşkun; Emine Baş; Bülent Karabulut; Deniz Nart; Taner Korkmaz; Dilek Yavuzer; Gökhan Demir; Gülen Doğusoy; Mehmet Artaç
Journal:  Mol Clin Oncol       Date:  2015-08-31

9.  The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma.

Authors:  Nuray Bassullu; Ilknur Turkmen; Murat Dayangac; Pinar Yagiz Korkmaz; Reyhan Yasar; Murat Akyildiz; Onur Yaprak; Yaman Tokat; Yildiray Yuzer; Gulen Bulbul Dogusoy
Journal:  Hepat Mon       Date:  2012-10-11       Impact factor: 0.660

10.  Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.

Authors:  Ulus Salih Akarca; Belkis Unsal; Orhan Sezgin; Kendal Yalcin; Meral Akdogan; Can Gonen; Feyza Gunduz; Seren Ozenirler; Abdullah Sonsuz; Dinc Dincer; Salim Basol Tekin; Idris Yucel; Hakan Akbulut; Canan Alkım; Ozgur Ozyilkan; Arzu Baygul; Zeynep Merve Cevik; Ramazan Idilman; On Behalf Of K Registry Study Group
Journal:  Turk J Gastroenterol       Date:  2021-12       Impact factor: 1.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.